title: Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia.
authors.affiliation: Department of Pediatrics, and.
authors.forename: Olli
authors.initials: O
authors.lastname: Ruuskanen
authors.affiliation: Department of Virology, University of Turku, Finland.
authors.forename: Matti
authors.initials: M
authors.lastname: Waris
authors.affiliation: Department of Pediatrics, and Department of Medicine, Turku University Hospital.
authors.forename: Leena
authors.initials: L
authors.lastname: Kainulainen
mesh_terms: D000361:Agammaglobulinemia / Q000150:complications; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D017074:Common Variable Immunodeficiency / Q000150:complications; D004359:Drug Therapy, Combination; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010850:Picornaviridae Infections / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012229:Rhinovirus; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a